Palisade Capital Management LLC Heron Therapeutics, Inc. Transaction History
Palisade Capital Management LLC
- $3.15 Billion
- Q2 2024
A detailed history of Palisade Capital Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 4,049,128 shares of HRTX stock, worth $8.06 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
4,049,128
Previous 3,732,241
8.49%
Holding current value
$8.06 Million
Previous $10.3 Million
37.08%
% of portfolio
0.45%
Previous 0.32%
Shares
23 transactions
Others Institutions Holding HRTX
# of Institutions
198Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$53.2 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$17.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$16.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$15.1 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.9 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $236M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...